Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -29.78 | 33.15 |
PEG Ratio (TTM) | -0.43 | 11.22 |
P/S Ratio (TTM) | 0.55 | 3.09 |
P/B Ratio (TTM) | 1.97 | 7.21 |
P/FCF Ratio (TTM) | 7.21 | 33.93 |
Price to 5YR AVG Earnings Ratio | -21.21 | 78.36 |
Price to 5YR AVG FCF Ratio | -17.60 | 604.51 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.98% | 8.30% |
ROE (TTM) | -7.68% | 19.95% |
Net Profit Margin (TTM) | -1.78% | 7.99% |
ROIC 5YR AVG | -4.23% | 25.16% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 29.87% | 140.00% | -65.07% |
Revenue | -0.28% | 52.37% | 33.17% |
Net Income | 31.37% | 144.22% | -73.68% |
Cash Flow | 164.53% | -407.84% | -220.23% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.47 | 1.26 |
Quick Ratio (TTM) | 1.03 | 1.04 |
D/E Ratio (TTM) | 0.56 | 0.37 |
Interest Coverage (TTM) | -1.22 | 0.03 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 2.61 | 4.87 |
LTL to 5YR AVG FCF | -1.66 | 41.71 |
Shares Outstanding Growth 5YR AVG | 1.20% | 6.88% |